This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Uniquest Pty Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Joseph Cherian - Innovator in Antimicrobial Therapeutics
Introduction
Joseph Cherian is a notable inventor based in Singapore, recognized for his contributions to the field of therapeutic compounds. His innovative work focuses on lipopeptide compounds, which have significant applications in antimicrobial treatments.
Latest Patents
Joseph Cherian holds a patent for "Lipopeptide compounds and their use." This invention pertains to certain lipopeptide compounds that comprise a cyclic peptide bearing a lipid side chain, collectively referred to as 'LP compounds.' These compounds exhibit antimicrobial properties, particularly against bacteria. The patent also covers pharmaceutical compositions that utilize these compounds for treating diseases mediated by microbes, especially bacterial infections.
Career Highlights
Joseph Cherian is associated with Uniquest Pty Limited, where he continues to advance his research in therapeutic compounds. His work has the potential to impact the medical field significantly, particularly in developing new antibacterial agents.
Collaborations
Joseph has collaborated with notable colleagues, including Rustum S Boyce and Cleofe Calanasan, contributing to a dynamic research environment that fosters innovation.
Conclusion
Joseph Cherian's work in developing lipopeptide compounds showcases his commitment to advancing antimicrobial therapies. His contributions are vital in addressing bacterial diseases and improving health outcomes.